Abstract:Clinical attention to functional tricuspid regurgitation (FTR) has been insufficient, with a common expectation that it will resolve spontaneously following the treatment of left heart diseases. With the ongoing advancements in understanding the right heart function and pathology, FTR is now recognized as a significant contributor to increased morbidity and mortality among cardiac diseases. As a result, clinical treatment for FTR has become increasingly proactive and aggressive. This review analyzes the causes of FTR from perspectives such as the anatomical structure of the tricuspid valve and the impact of left heart diseases. It describes the clinical manifestations of FTR, compares the criteria and measurement standards for assessing its severity, clarifies its prognosis, and summarizes the main clinical treatment approaches currently available for FTR. We propose that FTR is a relatively independent and emerging pathological condition of the tricuspid valve, resulting from secondary changes in the right heart caused by the progressive development of other diseases. We hope to draw the attention of cardiac surgeons to this condition and advocate for timely and appropriate surgical intervention.